It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Writer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
A refreshing gamble on Crispr delivery

Commentary / World Feb 27, 2023

A refreshing gamble on Crispr delivery

Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.

The U.S. needs five times as many child psychiatrists

Commentary / World Feb 13, 2023

The U.S. needs five times as many child psychiatrists

American kids are struggling with mental anxiety and other issues and there are too few trained adults available to help them.

Don't write off the retooled COVID-19 boosters

Commentary / World Jan 11, 2023

Don't write off the retooled COVID-19 boosters

Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.

Cancer vaccine hunt finally makes progress

Commentary / World Jan 4, 2023

Cancer vaccine hunt finally makes progress

A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.

Another Crispr first: New treatment wipes out teen's cancer

Commentary / World Dec 21, 2022

Another Crispr first: New treatment wipes out teen's cancer

Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.

Amgen has a contender in the weight-loss drug wars

Commentary / World Dec 2, 2022

Amgen has a contender in the weight-loss drug wars

Amgen’s obesity drug offers a new twist on proven methods to help people lose unwanted pounds.

Pfizer’s RSV vaccine succeeds where others failed

Commentary / World Nov 21, 2022

Pfizer’s RSV vaccine succeeds where others failed

Early data bodes well for Pfizer’s RSV shot, which would be given during pregnancy to protect infants in the early months of life.

New weight-loss drugs work, but who's paying?

Commentary / World Nov 16, 2022

New weight-loss drugs work, but who's paying?

Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren’t yet on board.

New COVID-19 variants have arrived. How worried should you be?

Commentary Oct 24, 2022

New COVID-19 variants have arrived. How worried should you be?

Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.

Don’t cancel your colonoscopy just yet

Commentary / World Oct 12, 2022

Don’t cancel your colonoscopy just yet

Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it’s a lot more complicated.

« 1 2 3 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

SUSTAINABLE JAPAN

Support our journalism

Staying informed during times of uncertainty is crucial, which is why The Japan Times is providing free access to select stories about the coronavirus pandemic. Please consider subscribing today and support our efforts to deliver the news that matters.
SUBSCRIBE NOW
The Japan Times circular logo

SPECIAL SUPPLEMENTS

Sponsored contents planned and edited by JT Media Enterprise Division.

広告出稿に関するおといあわせはこちらまで

Read more

SUPPLEMENTS BINDER

international-reports
  • Bridges by SMS
  • Global Insight
  • GMI Post
  • World Eye Reports
Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times